Physician profile
Adam M Moss
NPI 1093032435
$8,610.22
in general payments reported to CMS, 2019-2025
16 companies · $214 in 2025
The $214 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $58.86 · 2021: $94.93 · 2022: $190 · 2023: $180 · 2024: $7,689 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $7,475 · Food and Beverage: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $7,474.85 |
| Food and Beverage | $608.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $7,909.11 | 2020-2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished), Ce-Marked Kxla System |
| Alcon Vision LLC | $246.28 | 2019-2025 | Clareon, Clareon Panoptix Pro, Argos |
| Johnson & Johnson Surgical Vision, INC. | $151.17 | 2022-2025 | Veritas Vision System, Tecnis Iol, Tecnis Simplicity |
| Novartis Pharmaceuticals Corporation | $68.23 | 2022-2023 | |
| The Cameron-Ehlen Group, INC. | $40.96 | 2020-2022 | |
| Beaver-Visitec International, INC. | $32.03 | 2023 | |
| Harrow Eye, LLC | $20.44 | 2025 | Vevye |
| Biotissue Holdings INC. | $19.86 | 2024 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Oyster Point Pharma, INC. | $17.92 | 2025 | Ryzumvi, Tyrvaya |
| Dompe US, INC. | $15.88 | 2019 | |
| Ocular Therapeutix, INC. | $14.59 | 2024 | Dextenza |
| Coopervision INC. | $14.50 | 2023 | Myday Contact Lens |
| Tarsus Pharmaceuticals, INC. | $14.33 | 2025 | Xdemvy |
| Rxsight INC | $14.26 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.